2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Construction and validation of log odds of positive lymph nodes (LODDS)-based nomograms for predicting overall survival and cancer-specific survival in ovarian clear cell carcinoma patients

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Ovarian clear cell carcinoma (OCCC) is one of the special histologic subtypes of ovarian cancer. This study aimed to construct and validate log odds of positive lymph nodes (LODDS)-based nomograms for predicting the overall survival (OS) and cancer-specific survival (CSS) in patients with OCCC.

          Methods

          Patients who underwent surgical treatment between 2010 and 2016 were extracted from the Surveillance Epidemiology and End Results (SEER) database and the data of OCCC patients from the First Affiliated Hospital of Dalian Medical University were used as the external validation group to test the validity of the prognostic model. The best-fitting models were selected by stepwise Cox regression analysis. Survival probability was calculated by the Kaplan–Meier method, and the differences in survival time between subgroups were compared using the log-rank test. Each nomogram’s performance was assessed by the calibration plots, decision curve analysis (DCA), and receiver operating characteristics (ROC) curves.

          Results

          T stage, distant metastasis, marital status, and LODDS were identified as significant risk factors for OS. A model with four risk factors (age, T stage, stage, and LODDS value) was obtained for CSS. Nomograms were constructed by incorporating the prognostic factors to predict 1-, 3- and 5-year OS and CSS for OCCC patients, respectively. The area under the curve (AUC) range of our nomogram model for OS and CSS prediction ranged from 0.738-0.771 and 0.769-0.794, respectively, in the training cohort. The performance of this model was verified in the internal and external validation cohorts. Calibration plots illustrated nomograms have good prognostic reliability.

          Conclusion

          Predictive nomograms were constructed and validated to evaluate the OS and CSS of OCCC patients. These nomograms may provide valuable prognostic information and guide postoperative personalized care in OCCC.

          Related collections

          Most cited references49

          • Record: found
          • Abstract: found
          • Article: not found

          Nomograms in oncology: more than meets the eye.

          Nomograms are widely used as prognostic devices in oncology and medicine. With the ability to generate an individual probability of a clinical event by integrating diverse prognostic and determinant variables, nomograms meet our desire for biologically and clinically integrated models and fulfill our drive towards personalised medicine. Rapid computation through user-friendly digital interfaces, together with increased accuracy, and more easily understood prognoses compared with conventional staging, allow for seamless incorporation of nomogram-derived prognosis to aid clinical decision making. This has led to the appearance of many nomograms on the internet and in medical journals, and an increase in nomogram use by patients and physicians alike. However, the statistical foundations of nomogram construction, their precise interpretation, and evidence supporting their use are generally misunderstood. This issue is leading to an under-appreciation of the inherent uncertainties regarding nomogram use. We provide a systematic, practical approach to evaluating and comprehending nomogram-derived prognoses, with particular emphasis on clarifying common misconceptions and highlighting limitations.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization.

            The ability to parse tumors into subsets based on biomarker expression has many clinical applications; however, there is no global way to visualize the best cut-points for creating such divisions. We have developed a graphical method, the X-tile plot that illustrates the presence of substantial tumor subpopulations and shows the robustness of the relationship between a biomarker and outcome by construction of a two dimensional projection of every possible subpopulation. We validate X-tile plots by examining the expression of several established prognostic markers (human epidermal growth factor receptor-2, estrogen receptor, p53 expression, patient age, tumor size, and node number) in cohorts of breast cancer patients and show how X-tile plots of each marker predict population subsets rooted in the known biology of their expression.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              jModelTest: phylogenetic model averaging.

              jModelTest is a new program for the statistical selection of models of nucleotide substitution based on "Phyml" (Guindon and Gascuel 2003. A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood. Syst Biol. 52:696-704.). It implements 5 different selection strategies, including "hierarchical and dynamical likelihood ratio tests," the "Akaike information criterion," the "Bayesian information criterion," and a "decision-theoretic performance-based" approach. This program also calculates the relative importance and model-averaged estimates of substitution parameters, including a model-averaged estimate of the phylogeny. jModelTest is written in Java and runs under Mac OSX, Windows, and Unix systems with a Java Runtime Environment installed. The program, including documentation, can be freely downloaded from the software section at http://darwin.uvigo.es.
                Bookmark

                Author and article information

                Contributors
                URI : https://loop.frontiersin.org/people/1929629Role: Role: Role: Role: Role:
                Role: Role: Role:
                Role: Role: Role:
                Role: Role: Role: Role:
                Role: Role: Role:
                URI : https://loop.frontiersin.org/people/2133376Role: Role:
                Journal
                Front Oncol
                Front Oncol
                Front. Oncol.
                Frontiers in Oncology
                Frontiers Media S.A.
                2234-943X
                21 March 2024
                2024
                : 14
                : 1370272
                Affiliations
                [1] 1 Department of Gynecology and Obstetrics, The First Affiliated Hospital of Dalian Medical University , Dalian, Liaoning, China
                [2] 2 Department of Gynecology and Obstetrics, The Second Affiliated Hospital of Dalian Medical University , Dalian, Liaoning, China
                Author notes

                Edited by: Robb Hollis, University of Edinburgh, United Kingdom

                Reviewed by: Angelo Finelli, ULSS2 Marca Trevigiana, Italy

                Jessica Lim, Guy’s and St Thomas’ NHS Foundation Trust, United Kingdom

                *Correspondence: Fandou Kong, tg980927@ 123456126.com

                †These authors have contributed equally to this work

                Article
                10.3389/fonc.2024.1370272
                10991783
                38577328
                4ea46ca6-e2f3-4c26-a8f8-549f1b6ed457
                Copyright © 2024 Liu, Jing, Hooblal, Yang, Chen and Kong

                This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

                History
                : 14 January 2024
                : 11 March 2024
                Page count
                Figures: 6, Tables: 1, Equations: 2, References: 49, Pages: 10, Words: 3782
                Funding
                The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.
                Categories
                Oncology
                Original Research
                Custom metadata
                Gynecological Oncology

                Oncology & Radiotherapy
                lodds,ovarian clear cell carcinoma,nomogram,overall survival,cancerspecific survival

                Comments

                Comment on this article